“Issuance of the new patent for our oncology preclinical aPKCi inhibitor pipeline is an important part of our development strategy,” said Jed Latkin, CEO of Windtree Therapeutics. “We will continue ...
Gene Quinn is a patent attorney and a leading commentator ... My conversation this week with John White was much like any number of conversations we have had over the years over dinner or drinks.
But there's a more important number every investor should be monitoring these days. Since 2020, Plug Power's revenue has grown by 186%. This has given many investors a heavy dose of optimism about ...